Integral Molecular, a leader in membrane protein antibody discovery, in conjunction with Blood Systems Research Institute (BSRI), has identified potent inhibitory human antibodies against the debilitating mosquito-borne Chikungunya virus (CHIKV). The lead candidate, IM-CKV063, is one of the most potent antibodies against CHIKV isolated to date, and protects animals from CHIKV-induced lethality and arthritis. This work, described by Fong et al., appears in the current issue of the Journal of Virology (December 2014). Click here to read more.
12/10/14 | Science Center Companies
